What is the dosing regimen for norethindrone in a female patient of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norethindrone Dosing Regimens

Norethindrone dosing varies significantly by indication: for contraception use 0.35 mg daily continuously without breaks; for menstrual delay use 5 mg two to three times daily starting 3 days before expected menses; and for hormone replacement therapy use 0.5-1.0 mg daily for 12-14 days per month in sequential regimens or minimum 1 mg daily for continuous regimens. 1, 2, 3

Contraceptive Dosing

  • Take 0.35 mg orally once daily at the same time every day without any interruption between pill packs 4, 3
  • Administration must be continuous with no pill-free intervals, as progestin-only pills have a shorter half-life than combined hormonal contraceptives 4
  • When transitioning from combined hormonal contraceptives, start norethindrone on the first day of withdrawal bleeding to maintain continuous contraceptive protection 4
  • This timing maintains suppressed ovarian activity and reduces irregular bleeding risk 4
  • Drug effectiveness rate is 1.9 pregnancies per 100 woman-years with regular use 5

Menstrual Delay Dosing

  • Use 5 mg orally two to three times daily, starting 3 days before the expected period 2
  • Continue until menstruation is desired, then stop to allow withdrawal bleeding 2
  • This is NOT a contraceptive method—additional contraception is required if sexually active 2
  • The full 5 mg dose 2-3 times daily is necessary for reliable menstrual suppression 2

Hormone Replacement Therapy Dosing

Sequential Regimens

  • Use 10 mg daily for 12-14 days per month when combined with estrogen therapy 1, 6
  • This dosing induces regular withdrawal bleeding with secretory endometrial transformation 6

Continuous Regimens

  • Minimum dose of 1 mg daily when used continuously with estrogen 1
  • Doses of 0.5-1.0 mg daily have been studied with transdermal estradiol, all providing adequate endometrial protection 6

Combined Oral Contraceptive Formulations

  • Norethindrone acetate 1 mg/ethinyl estradiol 20 mcg: Take 1 pill daily for 24 days followed by 4 days of placebo 7
  • The 24-day active regimen reduces intracyclic bleeding compared to 21-day regimens (0.95 vs 1.63 days, p=0.005) 7
  • Norethindrone with ethinyl estradiol: Take 1 pill daily for 21 days followed by 7 days off 1
  • Only recommended for post-menarchal females aged 15 years and older 1

Critical Safety Considerations

Absolute Contraindications

  • Pregnancy, active or history of arterial thromboembolic disease, breast cancer or hormone-sensitive cancers 1, 2, 4
  • Undiagnosed vaginal bleeding, active liver disease or hepatic tumors 1, 2, 4
  • History of deep vein thrombosis or thromboembolic disease 1, 2, 4
  • Uncontrolled hypertension 2, 4

Drug Interactions

  • When taking rifamycins (rifampin, rifabutin, rifapentine), add barrier contraception as rifamycins substantially decrease norethindrone levels 8
  • This interaction applies to all hormonal contraceptives containing norethindrone 8

Common Pitfalls

  • Timing precision is critical for the 0.35 mg contraceptive dose—even small delays reduce efficacy due to short half-life 4, 3
  • Do not use norethindrone repeatedly for menstrual delay; consider alternative hormonal management for frequent use 2
  • Perform pregnancy testing if withdrawal bleeding does not occur before starting norethindrone 4
  • Breakthrough bleeding occurs more commonly with progestin-only pills but can be minimized by strict adherence to timing 4
  • Norethindrone is not suitable for pre-menarchal patients—safety and efficacy are not established 1

References

Guideline

Norethindrone Acetate Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norethisterone for Delaying Menstruation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contraceptive Management with Norethindrone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.